MDA asks Sarepta Therapeutics' CEO Chris Garabedian about next steps for this promising new drug for DMD

posted on January 7, 2013 - 9:11am
MDA is pushing forward on all levels to accelerate the pace at which we’re able to translate scientific discoveries into improved health outcomes for individuals living with muscle disease.

New content is being added every day. Please check back again.